GlassScriptPhysician profile
Aaron Storey
NPI 1134672553
$5,153.11
in general payments reported to CMS, 2019-2025
19 companies · $2,215 in 2025
The $2,215 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.32 · 2022: $1,199 · 2023: $735 · 2024: $971 · 2025: $2,215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,712 · Education: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,712.37 |
| Education | $208.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,623.13 | 2022-2025 | |
| Galderma Laboratories, L.P. | $678.22 | 2022-2025 | Nemluvio, Aklief |
| Sun Pharmaceutical Industries INC. | $336.06 | 2021-2025 | Winlevi, Absorica Ld, Ilumya |
| Amgen INC. | $332.55 | 2022-2025 | Otezla, Enbrel |
| Ucb, INC. | $328.83 | 2023-2025 | Bimzelx, Cimzia |
| Janssen Biotech, INC. | $291.14 | 2023-2025 | Tremfya |
| Genzyme Corporation | $285.70 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $198.55 | 2024-2025 | Dupixent |
| Pfizer INC. | $190.58 | 2025 | |
| Lilly USA, LLC | $163.23 | 2022-2025 | Taltz, Olumiant, Ebglyss |
| Leo Pharma INC. | $155.30 | 2022-2025 | Adbry |
| Arcutis Biotherapeutics, INC. | $154.32 | 2023-2025 | Zoryve |
| Merz North America, INC. | $135.91 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $125.82 | 2023-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $45.23 | 2022-2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $40.44 | 2023-2024 | Opzelura |
| Organon LLC | $35.02 | 2025 | Vtama |
| Bioventus LLC | $18.04 | 2022 | |
| Smith+Nephew, INC. | $15.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Storey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.